Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
10.1038/26155
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998). Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature, 395(6699), 237–243.

Authors 5
  1. Alicia A. Russo (first)
  2. Lily Tong (additional)
  3. Jie-Oh Lee (additional)
  4. Philip D. Jeffrey (additional)
  5. Nikola P. Pavletich (additional)
References 51 Referenced 416
  1. Sherr, C. J. Cancer cell cycles. Science 274, 1672–1677 (1996). (10.1126/science.274.5293.1672) / Science by CJ Sherr (1996)
  2. Hall, M. & Peters, G. Genetic alterations of cyclin, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68, 68–108 (1996). / Adv. Cancer Res. by M Hall (1996)
  3. Weinber, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995). (10.1016/0092-8674(95)90385-2) / Cell by RA Weinber (1995)
  4. Sherr, C. J. G1 phase progression cycling on cue. Cell 79, 551–555 (1994). (10.1016/0092-8674(94)90540-1) / Cell by CJ Sherr (1994)
  5. Hunter, T. & Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79, 573–582 (1994). (10.1016/0092-8674(94)90543-6) / Cell by T Hunter (1994)
  6. Serrano, M., Hannon, G. J. & Beach, D. Anew regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993). (10.1038/366704a0) / Nature by M Serrano (1993)
  7. Kamb, A. et al. Acell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994). (10.1126/science.8153634) / Science by A Kamb (1994)
  8. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994). (10.1038/368753a0) / Nature by T Nobori (1994)
  9. Caldas, C. et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27–32 (1994). (10.1038/ng0994-27) / Nature Genet. by C Caldas (1994)
  10. Hussussian, C. J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15–21 (1994). (10.1038/ng0994-15) / Nature Genet. by CJ Hussussian (1994)
  11. Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 23–26 (1994). (10.1038/ng0994-22) / Nature Genet. by A Kamb (1994)
  12. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996). (10.1016/S0092-8674(00)81079-X) / Cell by M Serrano (1996)
  13. Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506–510 (1995). (10.1038/375506a0) / Nature by J Koh (1995)
  14. Serrano, M., Gomez-Lahoz, E., DePinho, R. A., Beach, D. & Bar-Sagi, D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267, 249–252 (1995). (10.1126/science.7809631) / Science by M Serrano (1995)
  15. Yang, R., Gombart, A. F., Serrano, M. & Koeffler, H. P. Mutational effects on the p16INK4a tumor supressor protein. Cancer Res. 55, 2503–2506 (1995). / Cancer Res. by R Yang (1995)
  16. Ranade, K. et al. Mutations associated with familial melanoma impair p16INK4 function. Nature Genet. 10, 114–116 (1995). (10.1038/ng0595-114) / Nature Genet. by K Ranade (1995)
  17. Parry, D. & Peters, G. Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma. Mol. Cell. Biol. 16, 3844–3852 (1996). (10.1128/MCB.16.7.3844) / Mol. Cell. Biol. by D Parry (1996)
  18. Zhang, B. & Peng, Z. Defective folding of mutant p16(INK4) proteins encoded by tumor-derived alleles. J. Biol. Chem. 271, 28734–28737 (1996). (10.1074/jbc.271.46.28734) / J. Biol. Chem. by B Zhang (1996)
  19. Arap, W., Knudsen, E. S., Wang, J. Y., Cavenee, W. K. & Huang, H. J. Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma. Oncogene 14, 603–609 (1997). (10.1038/sj.onc.1200870) / Oncogene by W Arap (1997)
  20. Wolfel, T. et al. Ap16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284 (1995). (10.1126/science.7652577) / Science by T Wolfel (1995)
  21. Zuo, L. et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nature Genet. 12, 97–99 (1996). (10.1038/ng0196-97) / Nature Genet. by L Zuo (1996)
  22. Hannon, G. J. & Beach, D. p15INK4B is a potential effector of TGF β-induced cell cycle arrest. Nature 371, 257–261 (1994). (10.1038/371257a0) / Nature by GJ Hannon (1994)
  23. Hirai, H., Roussel, M. F., Kato, J. Y., Ashmun, R. A. & Sherr, C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15, 2672–2681 (1995). (10.1128/MCB.15.5.2672) / Mol. Cell. Biol. by H Hirai (1995)
  24. Guan, K. L. et al. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4. Mol. Biol. Cell 7, 57–70 (1996). (10.1091/mbc.7.1.57) / Mol. Biol. Cell by KL Guan (1996)
  25. Xiong, Y., Zhang, H. & Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7, 1572–1583 (1993). (10.1101/gad.7.8.1572) / Genes Dev. by Y Xiong (1993)
  26. Li, Y., Nichols, M. A., Shay, J. W. & Xiong, Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54, 6078–6082 (1994). / Cancer Res. by Y Li (1994)
  27. Parry, D., Bates, S., Mann, D. J. & Peters, G. Lack of cyclin D–Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14, 503–511 (1995). (10.1002/j.1460-2075.1995.tb07026.x) / EMBO J. by D Parry (1995)
  28. Lukas, J. et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375, 503–506 (1995). (10.1038/375503a0) / Nature by J Lukas (1995)
  29. Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J. & Pavletich, N. P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A–Cdk2 complex. Nature 382, 325–331 (1996). (10.1038/382325a0) / Nature by AA Russo (1996)
  30. De Bondt, H. L. et al. Crystal structure of cyclin-dependent kinase 2. Nature 363, 595–602 (1993). (10.1038/363595a0) / Nature by HL De Bondt (1993)
  31. Knighton, D. R. et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253, 407–413 (1991). (10.1126/science.1862342) / Science by DR Knighton (1991)
  32. Gorina, S. & Pavletich, N. P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001–1005 (1996). (10.1126/science.274.5289.1001) / Science by S Gorina (1996)
  33. Luh, F. Y. et al. Structure of the cyclin-dependent kinase inhibitor p19Ink4d. Nature 389, 999–1003 (1997). (10.1038/40202) / Nature by FY Luh (1997)
  34. Byeon, I. et al. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell 1, 421–431 (1998). (10.1016/S1097-2765(00)80042-8) / Mol. Cell by I Byeon (1998)
  35. Venkataramani, R., Swaminathan, K. & Marmostein, R. Crystal structure of the CDK4/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16INK4 mutations. Nature Struct. Biol. 5, 74–81 (1998). (10.1038/nsb0198-74) / Nature Struct. Biol. by R Venkataramani (1998)
  36. Jeffrey, P. D. et al. Mechanism of CDK activation revealed by the structure of cyclin A–CDK2 ocmplex. Nature 376, 313–320 (1995). (10.1038/376313a0) / Nature by PD Jeffrey (1995)
  37. Russo, A., Jeffrey, P. D. & Pavletich, N. P. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature Struct. Biol. 3, 696–700 (1996). (10.1038/nsb0896-696) / Nature Struct. Biol. by A Russo (1996)
  38. Coleman, K. G. et al. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem. 272, 18869–18874 (1997). (10.1074/jbc.272.30.18869) / J. Biol. Chem. by KG Coleman (1997)
  39. Brotherton, D. H. et al. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell cycle inhibitor p19INK4d. Nature 395, 244–250 (1998). (10.1038/26164) / Nature by DH Brotherton (1998)
  40. Zoller, M. J., Nelson, N. C. & Taylor, S. S. Affinity labeling of cAMP-dependent protein kinase with p-Fluorosulfonylbenzoyl adenosine. J. Biol. Chem. 256, 10837–10842 (1981). (10.1016/S0021-9258(19)68519-4) / J. Biol. Chem. by MJ Zoller (1981)
  41. Atherton-Fessler, S., Parker, L. L., Geahlen, R. L. & Piwnica-Worms, H. Mechanisms of p34cdc2 regualtion. Mol. Cell. Biol. 13, 1675–1685 (1993). (10.1128/MCB.13.3.1675) / Mol. Cell. Biol. by S Atherton-Fessler (1993)
  42. Fahraeus, R., Paramio, J. M., Ball, K. L., Lain, S. & Lane, D. P. Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A. Curr. Biol. 6, 84–91 (1996). (10.1016/S0960-9822(02)00425-6) / Curr. Biol. by R Fahraeus (1996)
  43. Gerber, M. R., Farrell, A., Deshaies, R. J., Herskowitz, I. & Morgan, D. O. Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins. Proc. Natl Acad. Sci. USA 92, 4651–4655 (1995). (10.1073/pnas.92.10.4651) / Proc. Natl Acad. Sci. USA by MR Gerber (1995)
  44. Stepanova, L., Leng, X., Parker, S. B. & Harper, J. W. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10, 1491–1502 (1996). (10.1101/gad.10.12.1491) / Genes Dev. by L Stepanova (1996)
  45. Reynisdottir, I., Polyak, K., Iavarone, A. & Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831–1845 (1995). (10.1101/gad.9.15.1831) / Genes Dev. by I Reynisdottir (1995)
  46. Meyerson, M. & Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14, 2077–2086 (1994). (10.1128/MCB.14.3.2077) / Mol. Cell. Biol. by M Meyerson (1994)
  47. Collaborative Computational Project, Number4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
  48. Jones, T. A., Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991). (10.1107/S0108767390010224) / Acta Crystallogr. A by TA Jones (1991)
  49. Brunger, A. T. X-PLOR, a System for Crystallography and NMR(Yale Univ. Press, New Haven, CT, 1991). / X-PLOR, a System for Crystallography and NMR by AT Brunger (1991)
  50. Kraulis, P. J. Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946–950 (1991). (10.1107/S0021889891004399) / J. Appl. Crystallogr. by PJ Kraulis (1991)
  51. Merrit, E. A. & Murphy, M. E. Raster3D Version 2.0: a program for photorealistic molecular graphics. Acta Crystallogr. D 50, 869–873 (1994). (10.1107/S0907444994006396) / Acta Crystallogr. D by EA Merrit (1994)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:39 a.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 8:42 p.m.)
Indexed 0 minutes ago (Aug. 23, 2025, 12:58 a.m.)
Issued 26 years, 11 months ago (Sept. 1, 1998)
Published 26 years, 11 months ago (Sept. 1, 1998)
Published Print 26 years, 11 months ago (Sept. 1, 1998)
Funders 0

None

@article{Russo_1998, title={Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a}, volume={395}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/26155}, DOI={10.1038/26155}, number={6699}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Russo, Alicia A. and Tong, Lily and Lee, Jie-Oh and Jeffrey, Philip D. and Pavletich, Nikola P.}, year={1998}, month=sep, pages={237–243} }